Skip to main content
Intermediate Technical IVT

DiGeorge Syndrome

Pronunciation: dee-ZHORZH

A genetic disorder caused by 22q11.2 deletion, commonly associated with conotruncal heart defects, thymic hypoplasia, and characteristic facial features.

Full Definition

DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is the most common microdeletion syndrome in humans, affecting approximately 1 in 4,000 live births. The condition results from a hemizygous deletion on chromosome 22 and is characterized by a constellation of features including congenital heart defects (particularly conotruncal anomalies), thymic hypoplasia leading to immunodeficiency, parathyroid dysfunction causing hypocalcemia, and distinctive facial features. Cardiac manifestations include tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch. The syndrome demonstrates variable expressivity, and some individuals may have only cardiac involvement without other classic features.

Usage

Usage note: Preferred term over velocardiofacial syndrome in cardiac contexts.

In Context

  • "Genetic testing confirmed DiGeorge syndrome in the infant with tetralogy of Fallot and neonatal hypocalcemia." — Genetics consultation
  • "The cardiac team coordinated with immunology for perioperative management of the DiGeorge syndrome patient." — Multidisciplinary care plan

Also known as

22q11.2 Deletion Syndrome Velocardiofacial Syndrome CATCH22

Don't confuse with

Williams Syndrome Noonan Syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON